Is HSIC a good stock to buy?
Henry Schein, Inc. · end-of-day data as of Nov 13, 2026
- PT$92.30 +7.1%
- ConsensusBuy · 16
- P/E vs sector-26.7%
- FCF yield+5.6%
- MAs3 of 4
- MACD0.17
- Sector▲ +15.9%
- Earnings in102d
- P/E23.6x
- RSI50
- Support-3.6%
- Resistance+2.0%
- Off 52w high-6.5%
- Volume1.3x
- Bollingerupper half
- News0.00
- P/E vs own+1.1%
- Trendsideways
- 52w range$69–$92
- ATR+3.0%
- Off ATH-7.0%
- InsidersNone in 90d
- MA20×50↑ in ~1d
Updates with the 15-min delayed price. Not a forecast or investment advice.
Is Henry Schein a good stock to buy?
Henry Schein is strong on 1 of the 4 questions about the business. The price is about usual: 23.6 times its earnings, near its 3-year median of 23.6 (Nov 13, 2026). pretickt does not say whether to buy or sell.
HSIC sales growth revenue growth
+1%a year, for the last 3 yearsHenry Schein's sales grew 1% a year for 3 years, to $13.18B in fiscal 2025.
HSIC analysts' forecast revenue estimates
+5%the sales they expect next fiscal year, on the lastAnalysts expect Henry Schein's sales to grow 5% to $13.84B in fiscal 2026 (12 analysts).
HSIC earnings vs estimates
6 of 8quarters above the analysts' estimateHenry Schein beat the analysts' profit estimate in 6 of its last 8 quarters, the latest on Nov 3, 2026.
HSIC insider selling
-$7.88Msold, net, by its executives in 12 monthsHenry Schein's executives and directors sold a net $7.88M of shares in the 12 months to Nov 13, 2026 ($8.58M sold, $692K bought).
HSIC number of employees
0%about as many people as a year beforeHenry Schein had 25,000 employees at the end of fiscal 2025, about as many as a year before.
HSIC CEO pay
$11.64Mfor fiscal 2024, 67% of it in stock and optionsHenry Schein paid its CEO $11.64M for fiscal 2024, 67% of it in stock and options.
HSIC financial health Altman Z-score
2.8Altman Z-score, safe above 3Henry Schein's Altman Z-score is 2.8 (Nov 13, 2026), between 1.8 and 3, the grey zone.
HSIC quality checks Piotroski score
7 of 9checks passedHenry Schein passes 7 of the 9 Piotroski checks in the 12 months to Sep 26, 2026; it misses on long-term debt and the current ratio.
HSIC biggest customers
under 10%of sales from any one customerNo customer made 10% of Henry Schein's sales in fiscal 2025.
HSIC in past recessions
pretickt analysis+1%its sales in the worst oneHenry Schein's sales grew through each of the last 2 US recessions (2008–09 and 2020).
HSIC price vs profit P/E ratio
23.6×a year's earningsHenry Schein's P/E ratio is 23.6 (Nov 13, 2026), near its 3-year median of 23.6.
HSIC price vs peers
pretickt analysis23.6×a year's earnings, against its peersInvestors pay 23.6 times Henry Schein's earnings (Nov 13, 2026), more than for Cencora (20.0) and Universal Health Services (8.1), less than for Cardinal Health (36.4) and McKesson (28.4).
HSIC analysts' target price target
+7%to their average targetAnalysts' average price target for Henry Schein is $92.30, 7% above the Nov 13, 2026 close of $86.22.
What is Henry Schein's P/E ratio?
Henry Schein's P/E ratio is 23.6 (Nov 13, 2026), near its 3-year median of 23.6. Investors pay 23.6 times Henry Schein's earnings (Nov 13, 2026), more than for Cencora (20.0) and Universal Health Services (8.1), less than for Cardinal Health (36.4) and McKesson (28.4).
Are insiders selling Henry Schein stock?
Henry Schein's executives and directors sold a net $7.88M of shares in the 12 months to Nov 13, 2026 ($8.58M sold, $692K bought).
How many employees does Henry Schein have?
Henry Schein had 25,000 employees at the end of fiscal 2025, about as many as a year before.
Who are Henry Schein's biggest customers?
No customer made 10% of Henry Schein's sales in fiscal 2025.
From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.